Itron officer Christopher E. Ware plans 194-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Christopher E. Ware, identified as an officer of Itron, Inc. (ITRI), gave notice of a planned sale of 194 common shares, with an aggregate market value of $18,907.43 and an approximate sale date of November 20, 2026. The shares were acquired through restricted stock vesting on November 19, 2026, as compensation. The notice states that the planned sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It lists two prior common-stock sales by Ware during the preceding three months: 195 shares on August 20, 2026, and 200 shares on August 24, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
vested equity award distribution financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What gross proceeds did Christopher E. Ware report for his earlier ITRI sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.